Esfandiari, Ehsanollah, McInnes, Iain B., Lindop, George, Huang, Fang Ping, Field, Max, Komai-Koma, Mousa, Wei, Xiao-Qing ![]() |
Abstract
Serum from patients with systemic lupus erythematosus (SLE) contained significantly higher concentrations of IL-18 than normal individuals. MRL/lpr mice, which develop spontaneous lupus-like autoimmune disease, also had higher serum levels of IL-18 than wild-type MRL/�� mice. Daily injections of IL-18 or IL-18 plus IL-12 resulted in accelerated proteinuria, glomerulonephritis, vasculitis, and raised levels of proinflammatory cytokines in MRL/lpr mice. IL-18-treated MRL/lpr mice also developed a “butterfly” facial rash resembling clinical SLE. In contrast, MRL/lpr mice treated with IL-18 plus IL-12 did not develop a facial rash. The facial lesion in the IL-18-treated mice showed epidermal thickening with intense chronic inflammation accompanied by increased apoptosis, Ig deposition, and early systemic Th2 response compared with control or IL-12 plus IL-18-treated mice. These data therefore show that IL-18 is an important mediator of lupus-like disease and may thus be a novel target for therapeutic intervention of spontaneous autoimmune diseases.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Dentistry |
Subjects: | Q Science > QR Microbiology > QR180 Immunology |
Publisher: | American Association of Immunologists |
ISSN: | 0022-1767 |
Last Modified: | 21 Oct 2022 09:14 |
URI: | https://orca.cardiff.ac.uk/id/eprint/35682 |
Citation Data
Cited 113 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |